| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4262779 | Transplantation Proceedings | 2007 | 7 Pages |
Abstract
This analysis, based on findings from two clinical trials, suggested that everolimus was more cost-effective than MMF versus azathioprine in the first 6 months after heart transplantation. Data from a head-to-head trial are required to confirm these results.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
L. Annemans, H. Lemkuhl, G. Tenderich, U. Schulz, X.L. Yang, J.F. Ricci, R. Hetzer,